Cover Image
市場調查報告書

中國的Ossotide市場分析

Investigation Report on China Ossotide Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 333487
出版日期 內容資訊 英文 35 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的Ossotide市場分析 Investigation Report on China Ossotide Market, 2010-2019
出版日期: 2015年06月18日 內容資訊: 英文 35 Pages
簡介

中國的Ossotide市場年度銷售額,從2005年的6,000萬人民幣,到2014年達46,400萬人民幣,以26%以上的年複合成長率成長。中國市場規模,預計今後數年維持成長。

本報告提供中國的Ossotide市場相關調查分析、市場規模、市場佔有率、零售價格、主要製造商、市場預測等相關的系統性資訊。

第1章 Ossotide的相關概念

  • 適應
  • 全球市場銷售情形

第2章 中國的Ossotide的市場簡介

  • 中國的Ossotide的專利、核準情況
  • 主要製造商
  • 市場規模

第3章 中國的Ossotide銷售分析

  • 銷售額
  • 銷售額數量

第4章 中國的Ossotide主要廠商的市場佔有率分析

  • 市場佔有率:各銷售額
  • 市場佔有率:各銷售數量

第5章 中國的Ossotide的各劑型分析

  • 市場佔有率 (各劑型) :各銷售額
  • 市場佔有率 (各劑型) :各銷售數量

第6章 中國的Ossotide的醫院用標準價格

  • Harbin Sanctity Pharmaceutical Co., Ltd
  • Kaifeng Canon Pharmaceutical Co., Ltd
  • Nanjing Xinbai Pharmaceutical Co., Ltd
  • Harbin Medisan Pharmaceutical Co., Ltd
  • Harbin Songhe Pharmaceutical Co., Ltd
  • Heilongjiang Jiangshi Pharmaceutical Co., Ltd
  • ZBD Pharmaceutical

第7章 中國市場的Ossotide的主要製造商

  • Harbin Sanctity Pharmaceutical Co., Ltd
  • Harbin Medisan Pharmaceutical Co., Ltd
  • Heilongjiang Jiangshi Pharmaceutical Co., Ltd
  • Harbin Songhe Pharmaceutical Co., Ltd
  • Kaifeng Canon Pharmaceutical Co., Ltd

第8章 中國的Ossotide的市場預測

  • 市場規模的預測
  • 競爭情形的預測

圖表

目錄
Product Code: 1506229

According to statistics, the incidence of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of degraded joint function, is also common to see. With the ageing population in China, over 60% of elder people aged above 60 suffer from osteoarthritis, says a study. Patients with osteoarthritis typically show reduced mobility and life quality caused by joint pain, malformation and joint dysfunction.

Ossotide can not only regulate bone metabolism, stimulate osteoblast proliferation, accelerate new bone formation but also regulate calcium-phosphorus metabolism, increase calcium deposits so as to prevent osteoporosis. Ossotide injection and compound ossotide injection was first developed by Nanjing Xinbai Pharmaceutical Co., Ltd which was formerly Nanjing Biochemical Pharmaceutical Factory. In recent years, compound ossotide injection market has shown increasingly fierce competition as it is going from short supply to oversupply, from huge profits to meager profit. Besides, the rise in raw material price has stressed the profit margins.

After entering China market, ossotide is generally growing despite a decline in 2013 with annual sales value rising from less than CNY 60 million in 2005 to CNY 464 million in 2014 and CAGR during this period reaching over 26%. According to CRI's market survey, ossotide in the Chinese market mainly come from Harbin Medisan Pharmaceutical Co., Ltd, ZBD Pharmaceutical, Heilongjiang Jiangshi Pharmaceutical Co., Ltd, among which Harbin Medisan Pharmaceutical Co., Ltd has the largest market share of about 19% for sales value in 2014.

The market size of ossotide is expected to keep growing in the next few years in China.

Readers can get at least the following information from this report:

  • market size of ossotide in China
  • competitive landscape of ossotide in Chinese market
  • price of ossotide made by different enterprises in China
  • market outlook of ossotide in China

The author suggests the following groups of people purchase this report:

  • manufacturers of drugs for bones and muscles
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

Table of Contents

1. Related Concepts of Ossotide

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Ossotide in China

  • 2.1. Patent and Approval Status of Ossotide in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Ossotide in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Ossotide in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Ossotide in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value

5.2Share of Different Dosage Forms by Sales Volume

6. Reference Price of Ossotide in Chinese Hospitals in 2014

  • 6.1. Harbin Sanctity Pharmaceutical Co., Ltd (Trade Name: Gu Yue)
  • 6.2. Kaifeng Canon Pharmaceutical Co., Ltd
  • 6.3. Nanjing Xinbai Pharmaceutical Co., Ltd (Trade Name: Gu Qiang)
  • 6.4. Harbin Medisan Pharmaceutical Co., Ltd (Trade Name: Mai Jin Li)
  • 6.5. Harbin Songhe Pharmaceutical Co., Ltd (Trade Name: Song He)
  • 6.6. Heilongjiang Jiangshi Pharmaceutical Co., Ltd (Trade Name: Gu Jie)
  • 6.7. ZBD Pharmaceutical

7. Major Manufacturers of Ossotide in Chinese Market, 2010-2014

  • 7.1. Harbin Sanctity Pharmaceutical Co., Ltd
  • 7.2. Harbin Medisan Pharmaceutical Co., Ltd
  • 7.3. Heilongjiang Jiangshi Pharmaceutical Co., Ltd
  • 7.4. Harbin Songhe Pharmaceutical Co., Ltd
  • 7.5. Kaifeng Canon Pharmaceutical Co., Ltd

8. Market Outlook of Ossotide in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Approval Information of Ossotide in China
  • Chart Sales Status of Ossotide in China
  • Chart Sales Value of Ossotide in China, 2010-2014
  • Chart Sales Value of Ossotide in Some Regions in China, 2010-2014
  • Chart Sales Volume of Ossotide in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Ossotide for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Ossotide Made by Harbin Medisan in China, 2010-2014
  • Chart Sales Value and Market Share of Ossotide Made by Harbin Sanctity in China, 2010-2014
  • Chart Sales Value and Market Share of Ossotide Made by Harbin Songhe in China, 2010-2014
  • Chart Sales Value and Market Share of Ossotide Made by ZBD in China, 2010-2014
  • Chart Sales Value and Market Share of Ossotide Made by Heilongjiang Jiangshi in China, 2010-2014
  • Chart Sales Value and Market Share of Ossotide Injection in China, 2010-2014
  • Chart Sales Value and Market Share of Ossotide Tablet in China, 2010-2014
  • Chart Sales Volume and Market Share of Ossotide Injection, 2010-2014
  • Chart Price of Ossotide Made by Harbin Sanctity Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Ossotide Made by Kaifeng Canon Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Ossotide Made by Nanjing Xinbai Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Ossotide Made by Harbin Medisan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Ossotide Made by Harbin Songhe Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Ossotide Made by Heilongjiang Jiangshi Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Ossotide Made by ZBD Pharmaceutical in Some Chinese Cities in 2014
Back to Top